Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/Sulbactam (2:1) for Respiratory and Urinary Tract Infections
NCT01897831Phase 4Unknown
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- Aug 2011
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of piperacillin, sulbactam sodium in respiratory tract infection (RTI), urinary tract infection (UTI), sponsored by Xiangbei Welman Pharmaceuticals. Status: unknown.
02
Drugs
piperacillinsulbactam sodium
03
Conditions
respiratory tract infection (RTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT01897831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897831.